PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING OF CREATININE-DRUG INTERACTION IN CHRONIC KIDNEY DISEASE POPULATION.

被引：0
|
作者：
Takita, H. [1 ,2 ]
Scotcher, D. [1 ]
Chinnadurai, R. [3 ]
Kalra, P. [3 ]
Galetin, A. [1 ]
机构：
[1] Univ Manchester, Manchester, Lancs, England
[2] Asahi Kasei Pharma, Shizuoka, Japan
[3] Salford Royal NHS Fdn Trust, Salford, Lancs, England
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII-130
引用
收藏
页码：S113 / S114
页数：2
相关论文
共 50 条
  • [1] Physiologically-Based Pharmacokinetic Modelling of Creatinine-Drug Interactions in the Chronic Kidney Disease Population
    Takita, Hiroyuki
    Scotcher, Daniel
    Chinnadurai, Rajkumar
    Kalra, Philip A.
    Galetin, Aleksandra
    [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2020, 9 (12): : 695 - 706
  • [2] MECHANISTIC PBPK MODELING OF CREATININE-DRUG INTERACTIONS IN CHRONIC KIDNEY DISEASE POPULATION.
    Takita, H.
    Scotcher, D.
    Chinnadurai, R.
    Kalra, P.
    Galetin, A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S59 - S60
  • [3] MECHANISTIC PBPK MODELING OF CREATININE-DRUG INTERACTIONS IN CHRONIC KIDNEY DISEASE POPULATION.
    Takita, H.
    Scotcher, D.
    Chinnadurai, R.
    Kalra, P.
    Galetin, A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S85 - S85
  • [4] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING OF ESOMEPRAZOLE IN THE HEPATIC IMPAIRMENT POPULATION.
    Hoang, T.
    Arya, V.
    Zhang, X.
    Ayyoub, A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S86 - S86
  • [5] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING OF ESOMEPRAZOLE IN THE HEPATIC IMPAIRMENT POPULATION.
    Hoang, T.
    Arya, V.
    Zhang, X.
    Ayyoub, A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S79 - S79
  • [6] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING FOR ASSESSMENT OF THE DRUG-DRUG INTERACTION POTENTIAL OF ZAVEGEPANT
    Ke, A.
    Callegari, E.
    Bhardwaj, R.
    Varma, M.
    Muto, C.
    Bertz, R.
    Sahasrabudhe, V.
    Liu, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S107 - S107
  • [7] Understanding Statin-Roxadustat Drug-Drug-Disease Interaction Using Physiologically-Based Pharmacokinetic Modeling
    Dong, Jin
    Garcia, Luna Prieto
    Huang, Yingbo
    Tang, Weifeng
    Lundahl, Anna
    Elebring, Marie
    Ahlstrom, Christine
    Vildhede, Anna
    Sjogren, Erik
    Nagard, Mats
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (04) : 825 - 835
  • [8] Physiologically-Based Pharmacokinetic Modeling of Macitentan: Prediction of Drug–Drug Interactions
    Ruben de Kanter
    Patricia N. Sidharta
    Stéphane Delahaye
    Carmela Gnerre
    Jerome Segrestaa
    Stephan Buchmann
    Christopher Kohl
    Alexander Treiber
    [J]. Clinical Pharmacokinetics, 2016, 55 : 369 - 380
  • [9] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING OF OAT1/3 ACTIVITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE.
    Dubinsky, S.
    Malik, P.
    Edginton, A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S19 - S19
  • [10] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING OF ESOMEPRAZOLE IN THE HEPATIC IMPAIRMENT POPULATION
    Hoang, T.
    Arya, V.
    Zhang, X.
    Ayyoub, A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S5 - S5
12345